Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Psoriasis”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00733954
What this trial is testing

Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Galderma R&D 250
Large-scale testing (Phase 3)Study completedNCT02326272
What this trial is testing

Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)

Who this might be right for
PsoriasisPlaque Psoriasis
UCB Biopharma S.P.R.L. 227
Post-approval studies (Phase 4)UnknownNCT01443338
What this trial is testing

Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Psoriasis Vulgaris - CHINA201002016-2

Who this might be right for
Psoriasis Vulgaris
Ministry of Health, China 720
Large-scale testing (Phase 3)Ended earlyNCT01708603
What this trial is testing

P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Bausch Health Americas, Inc. 1,831
Large-scale testing (Phase 3)Study completedNCT02326298
What this trial is testing

An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)

Who this might be right for
PsoriasisPlaque Psoriasis
UCB Biopharma S.P.R.L. 234
Testing effectiveness (Phase 2)Study completedNCT00773734
What this trial is testing

Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)

Who this might be right for
PsoriasisPlaque-type Psoriasis
Amgen 352
Large-scale testing (Phase 3)Looking for participantsNCT06842199
What this trial is testing

Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis Patients
Beijing InnoCare Pharma Tech Co., Ltd. 383
Testing effectiveness (Phase 2)Study completedNCT00601107
What this trial is testing

Evaluate the Safety and Effectiveness of Doxercalciferol Capsules in Participants With Moderate to Severe Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Genzyme, a Sanofi Company 111
Testing effectiveness (Phase 2)Study completedNCT02933528
What this trial is testing

Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries, Inc. 24
Early research (Phase 1)Study completedNCT05504317
What this trial is testing

AK111 in Subjects With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Psoriasis
Akeso 48
Large-scale testing (Phase 3)WithdrawnNCT01936688
What this trial is testing

Evaluate the Efficacy and Safety/Tolerability of Subcutaneous MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-012)

Who this might be right for
Plaque-type Psoriasis
Sun Pharmaceutical Industries Limited
Large-scale testing (Phase 3)Study completedNCT01970488
What this trial is testing

Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 350
Testing effectiveness (Phase 2)Study completedNCT04612699
What this trial is testing

Jaktinib in Participants With Moderate to Severe Psoriasis

Who this might be right for
Moderate-to-Severe Plaque Psoriasis
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 123
Large-scale testing (Phase 3)Study completedNCT03536884
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Chronic Plaque Psoriasis
UCB Biopharma SRL 743
Post-approval studies (Phase 4)Ended earlyNCT00697593
What this trial is testing

ChangE From Any Systemic psoriasiS therapY to Raptiva

Who this might be right for
Chronic Plaque Psoriasis
Merck KGaA, Darmstadt, Germany 70
Large-scale testing (Phase 3)Study completedNCT06586112
What this trial is testing

Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Alumis Inc 912
Large-scale testing (Phase 3)Study completedNCT01646177
What this trial is testing

A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3)

Who this might be right for
Psoriasis
Eli Lilly and Company 1,346
Not applicableStudy completedNCT02954081
What this trial is testing

APremilast After FumaRic Acid Ester Treatment

Who this might be right for
Psoriasis
Amgen 687
Large-scale testing (Phase 3)Looking for participantsNCT07250802
What this trial is testing

A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Takeda 110
Large-scale testing (Phase 3)Study completedNCT00747344
What this trial is testing

Trial to Look at the Safety and Effectiveness of Ustekinumab in Korean and Taiwanese Subjects With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Centocor, Inc. 121
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation